Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
37.7M
-
Shares change
-
-3.1M
-
Total reported value, excl. options
-
$226M
-
Value change
-
-$18.9M
-
Put/Call ratio
-
0.47
-
Number of buys
-
48
-
Number of sells
-
-64
-
Price
-
$5.99
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2021
157 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q2 2021.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.7M shares
of 112M outstanding shares and own 33.59% of the company stock.
Largest 10 shareholders include ArrowMark Colorado Holdings LLC (7.67M shares), BlackRock Inc. (5.24M shares), STATE STREET CORP (4.99M shares), VANGUARD GROUP INC (3.28M shares), Park West Asset Management LLC (1.67M shares), GEODE CAPITAL MANAGEMENT, LLC (1.16M shares), FIERA CAPITAL CORP (1.09M shares), NORTHERN TRUST CORP (1M shares), TWO SIGMA ADVISERS, LP (984K shares), and TWO SIGMA INVESTMENTS, LP (828K shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.